vs
Side-by-side financial comparison of BRT Apartments Corp. (BRT) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
BRT Apartments Corp. is the larger business by last-quarter revenue ($24.3M vs $12.6M, roughly 1.9× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -17.8%, a 268.5% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 1.3%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 1.9%).
BRT Apartments Corp is a publicly traded real estate investment trust that owns, operates, and develops multi-family residential properties primarily across high-growth markets in the United States. Its core portfolio consists of garden-style and mid-rise apartment communities, serving diverse renter groups while targeting long-term asset value appreciation and stable dividend returns for its shareholders.
BRT vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.3M | $12.6M |
| Net Profit | $-4.3M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | -14.3% | — |
| Net Margin | -17.8% | 250.7% |
| Revenue YoY | 1.3% | 24080.8% |
| Net Profit YoY | -108.7% | 250.9% |
| EPS (diluted) | $-0.23 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.3M | $12.6M | ||
| Q3 25 | $24.4M | $0 | ||
| Q2 25 | $24.2M | $0 | ||
| Q1 25 | $24.1M | $12.0K | ||
| Q4 24 | $24.0M | $52.0K | ||
| Q3 24 | $24.4M | $65.0K | ||
| Q2 24 | $23.9M | $114.0K | ||
| Q1 24 | $23.4M | $140.0K |
| Q4 25 | $-4.3M | $31.5M | ||
| Q3 25 | $-2.7M | $-7.4M | ||
| Q2 25 | $-2.6M | $-1.7M | ||
| Q1 25 | $-2.4M | $-13.9M | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $-2.2M | $-17.1M | ||
| Q2 24 | $-2.3M | $-17.9M | ||
| Q1 24 | $-3.2M | $-12.7M |
| Q4 25 | -14.3% | — | ||
| Q3 25 | -13.7% | — | ||
| Q2 25 | -12.2% | — | ||
| Q1 25 | -11.3% | -122758.3% | ||
| Q4 24 | -14.3% | — | ||
| Q3 24 | -11.7% | -28604.6% | ||
| Q2 24 | -11.6% | -16720.2% | ||
| Q1 24 | -14.0% | -9987.1% |
| Q4 25 | -17.8% | 250.7% | ||
| Q3 25 | -11.1% | — | ||
| Q2 25 | -10.6% | — | ||
| Q1 25 | -9.8% | -115550.0% | ||
| Q4 24 | -8.6% | — | ||
| Q3 24 | -9.0% | -26380.0% | ||
| Q2 24 | -9.8% | -15668.4% | ||
| Q1 24 | -13.5% | -9049.3% |
| Q4 25 | $-0.23 | $0.56 | ||
| Q3 25 | $-0.14 | $-0.13 | ||
| Q2 25 | $-0.14 | $-0.03 | ||
| Q1 25 | $-0.12 | $-0.25 | ||
| Q4 24 | $-0.10 | — | ||
| Q3 24 | $-0.12 | $-0.32 | ||
| Q2 24 | $-0.13 | $-0.33 | ||
| Q1 24 | $-0.17 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $25.1M | $40.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $177.2M | $59.0M |
| Total Assets | $709.8M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.1M | $40.3M | ||
| Q3 25 | $21.1M | $48.6M | ||
| Q2 25 | $23.6M | $31.2M | ||
| Q1 25 | $24.4M | $48.9M | ||
| Q4 24 | $27.9M | $52.9M | ||
| Q3 24 | $45.8M | $76.3M | ||
| Q2 24 | $18.9M | $63.5M | ||
| Q1 24 | $21.3M | $82.3M |
| Q4 25 | $177.2M | $59.0M | ||
| Q3 25 | $186.7M | $26.5M | ||
| Q2 25 | $192.1M | $32.8M | ||
| Q1 25 | $198.5M | $33.8M | ||
| Q4 24 | $205.0M | $46.1M | ||
| Q3 24 | $209.9M | $65.5M | ||
| Q2 24 | $214.7M | $80.5M | ||
| Q1 24 | $220.7M | $96.2M |
| Q4 25 | $709.8M | $68.9M | ||
| Q3 25 | $714.2M | $54.2M | ||
| Q2 25 | $699.6M | $62.1M | ||
| Q1 25 | $703.9M | $77.7M | ||
| Q4 24 | $713.5M | $110.5M | ||
| Q3 24 | $717.7M | $135.2M | ||
| Q2 24 | $694.7M | $149.9M | ||
| Q1 24 | $699.5M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.1M | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.1M | $-8.4M | ||
| Q3 25 | $9.1M | $17.4M | ||
| Q2 25 | $8.5M | $-17.7M | ||
| Q1 25 | $246.0K | $-4.0M | ||
| Q4 24 | $24.1M | $-23.4M | ||
| Q3 24 | $9.0M | $12.8M | ||
| Q2 24 | $6.9M | $-18.7M | ||
| Q1 24 | $653.0K | $5.9M |
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BRT
| Unconsolidated Joint Ventures | $13.2M | 54% |
| Other | $11.1M | 46% |
SPRO
Segment breakdown not available.
